Venus Concept Inc (Venus) is a medical device company that develops and manufactures non-invasive aesthetic equipment. the company offers aesthetic devices such as venus swan, a non-invasive body contouring device used for reducing wrinkles, cellulite and circumferential fat reduction and tightening of the skin. It provides venus viva for facial remodeling and resurfacing, venus versa for skin restoration and texture and venus legacy, a workstation that offers body contouring, skin tightening and wrinkle reduction. Venus offers technical support and clinical support services. Its brands include ARTAS iXi, NeoGraft, Venus Velocity and Venus Epileve, among others. The company operates globally. Venus is headquartered in Toronto, Ontario, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Venus Concept Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Venus Concept Inc Company Overview
- Venus Concept Inc Company Snapshot
- Venus Concept Inc Pipeline Products and Ongoing Clinical Trials Overview
- Venus Concept Inc - Pipeline Analysis Overview
- Venus Concept Inc - Key Facts
- Venus Concept Inc - Major Products and Services
- Venus Concept Inc Pipeline Products by Development Stage
- Venus Concept Inc Ongoing Clinical Trials by Trial Status
- Venus Concept Inc Pipeline Products Overview
- AI.ME Robotic System
- AI.ME Robotic System Product Overview
- Venus Aime
- Venus Aime Product Overview
- Venus Aime Clinical Trial
- Venus Aime - Tissue Excision
- Venus Aime - Tissue Excision Product Overview
- Venus Concept Inc - Key Competitors
- Venus Concept Inc - Key Employees
- Venus Concept Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Venus Concept Inc, Recent Developments
- Feb 06, 2024: Venus Concept to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
- Jan 24, 2024: Venus Concept Announces Review of Strategic Alternatives
- Jan 17, 2024: Venus Concept Launches Venus Prime
- Dec 18, 2023: Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
- Nov 14, 2023: Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
- Nov 01, 2023: Venus Concept Launches Venus Versa Pro, Its New Multi-Application Platform for Face and Body Treatments
- Oct 12, 2023: Venus Concept Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations
- Oct 05, 2023: Venus Concept Announces Debt Restructuring, Preliminary Third Quarter 2023 Revenue Results and Updates Fiscal Year 2023 Revenue Guidance
- Sep 14, 2023: Venus Concept Receives 510(k) Clearance for the Venus Versa Pro System, Its New Multi-Application Platform
- Sep 06, 2023: Venus Concept to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Venus Concept Inc Pipeline Products and Ongoing Clinical Trials Overview
- Venus Concept Inc Pipeline Products by Equipment Type
- Venus Concept Inc Pipeline Products by Indication
- Venus Concept Inc Ongoing Clinical Trials by Trial Status
- Venus Concept Inc, Key Facts
- Venus Concept Inc, Major Products and Services
- Venus Concept Inc Number of Pipeline Products by Development Stage
- Venus Concept Inc Pipeline Products Summary by Development Stage
- Venus Concept Inc Ongoing Clinical Trials by Trial Status
- Venus Concept Inc Ongoing Clinical Trials Summary
- AI.ME Robotic System - Product Status
- AI.ME Robotic System - Product Description
- Venus Aime - Product Status
- Venus Aime - Product Description
- Venus Aime - Clinical Evaluation of the Safety and Efficacy of Aime Robotic Mechanical Coring Device for the Treatment of Moderate to Severe Facial Wrinkles
- Venus Aime - Pilot Study for the Clinical Evaluation of Mechanical Coring to Achieve Directional Skin Tightening
- Venus Aime - Tissue Excision - Product Status
- Venus Aime - Tissue Excision - Product Description
- Venus Concept Inc, Key Employees
- Venus Concept Inc, Other Locations
- Venus Concept Inc, Subsidiaries
- Glossary
- Venus Concept Inc Pipeline Products by Equipment Type
- Venus Concept Inc Pipeline Products by Development Stage
- Venus Concept Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Prollenium Medical Technologies Inc
- Yolo Medical Inc
- SharpLight
